AI assistant
NEOGENOMICS INC — Director's Dealing 2019
Mar 5, 2019
32227_dirs_2019-03-05_09c8d491-62c9-44a5-bcb6-34aa75d1a942.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-03-01
Reporting Person: Bonello William (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-01 | Common Stock | A | 6735 | — | Acquired | 6735 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-01 | Stock Option (Right to Buy) | $19.6 | A | 41167 | Acquired | 2024-03-01 | Common Stock (41167.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (80334.0) | 80334 | Direct |
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (79963.0) | 79963 | Direct |
Footnotes
F1: On March 1, 2019, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
F2: On February 26, 2018, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
F3: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.